DiaSorin Receive Clearance for LIAISON® CMV and EBV Assays
go back to news archivesDiaSorin Inc. have recently received FDA clearance for their LIAISON® Cytomegalovirus assays, including CMV IgG/CMV IgM and Epstein-Barr Virus assays, including VCA IgM, VCA IgG and EBNA IgG
The LIAISON® analyser combines a flexible operating mode with a broad assay menu and leads to high efficiency due to its long walk-away time. The possibility to run up to 15 different assays at a time provides for rational everyday testing even for low numbers of samples. Moreover, a throughput of up to 180 determination per hour allows LIAISON® to cope easily with a very high volume of samples. It is easy to use due to its touch-screen monitor, clear software structure and the Reagent Integral which contains all assay-specific reagents.
"Flash" chemiluminescence detection system
Paramagnetic microparticle solid phase
Sample and reagent continuous loading
Random access or batch mode
2-point calibration
STAT
Autodilution
Maximum through put: ~180 results/h
Source : DiaSorin Inc. [USA] View archived contact details
Is a subsidiary/distributor for
DiaSorin S.p.A., Italy View Company Information
Posted on July 25, 2005
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
USP Chapter <86> and the Move to Recombinant Methods
29 Apr 2025 -
2025 Novogene Sequencing Symposium
8 May 2025 -
Explore the Future of Sterility Testing with Rapid Micro Biosystems®
14 May 2025 -
Understanding USP <73> to Accelerate Sterility Testing for Short-Life Products
14 May 2025 -
British Society For Microbial Technology 40th Anniversary Microbiology Conference
15 May 2025 -
How Is VIDAS® KUBE™ Transforming Food Pathogen Detection?
19 May 2025 -
Sampling and Microbial Testing of Water and Data Trending
20 May 2025 -
European Microbiology Conference and Workshop 2025
20 May 2025 -
Future Labs Live 2025
27 May 2025 -
2025 Endotoxin Testing Summit
10 Jun 2025